Editorial Volume 2 Issue 6
1Editor-in-Chief, Journal of Lung Pulmonary and Respiratory Research, USA
210th
3Department of Disease Control, Ministry of Public Health, Thailand
4Department of Pathology, Chiang Mai University, Thailand
Correspondence: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Changklan Muang Chiang Mai 50100 Thailand, Tel 66 53 140767, Fax ÿ66 53 140773
Received: December 11, 2015 | Published: December 14, 2015
Citation: Cheepsattayakorn A, Cheepsattayakorn R. Asbestosis. J Lung Pulm Respir Res. 2015;2(6):132. DOI: 10.15406/jlprr.2015.02.00064
Asbestosis, a chronic lung disease that develops from inhalation of asbestos fibers, which contribute to lung tissue scarring. Asbestos fibers, a natural mineral product are heat-resistant fibrous silicate. Chrysotile is by far the most common type of asbestos fibers produced in the world and commercially virtual used in the United States. The symptoms usually don’t present until many years after continued exposure. Prolonged exposure can cause shortness of breath. Its production and use increased significantly between 1877 and 1967. Several previous studies indicated asbestos as a predisposing factor for malignant mesothelioma and bronchogenic carcinoma. Many cases come from work place exposure to asbestos before the United States federal laws regulating it were enacted in the mid-1970s. Today, its handling is strictly regulated. If we follow the employer’s safety procedures, acquiring asbestosis is extremely unlikely. According to the American Lung Association (ALA), more than 3, 000 deadly cases of it found in the United States from 1999 to 2004. Only relieving the patient’s symptoms is the focusing treatment.
None.
The author declares no conflict of interest.
©2015 Cheepsattayakorn, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.
World Tuberculosis Day (March 24) provides the opportunity to raise awareness about TB-related
problems and solutions and to support worldwide TB-control efforts. While great strides have been made to control and cure TB, people
still get sick and die from this disease in our country. On this event, we request researchers to spread more information and awareness
on this by their article submissions towards our JLPRR. For this we are rendering 25% partial waiver for articles submitted on or before
March 24th.